873436-91-0,MFCD18251588
Catalog No.:AA00GXXK

873436-91-0 | Pu-h 71

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$30.00   $21.00
- +
5mg
98%
in stock  
$87.00   $61.00
- +
50mg
98%
in stock  
$373.00   $261.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00GXXK
Chemical Name:
Pu-h 71
CAS Number:
873436-91-0
Molecular Formula:
C18H21IN6O2S
Molecular Weight:
512.3678
MDL Number:
MFCD18251588
SMILES:
CC(NCCCn1c(Sc2cc3OCOc3cc2I)nc2c1ncnc2N)C
NSC Number:
752199
Properties
Computed Properties
 
Complexity:
521  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
7  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.2  

Downstream Synthesis Route

[1]He,Huazhong;Zatorska,Danuta;Kim,Joungnam;Aguirre,Julia;Llauger,Laura;She,Yuhong;Wu,Nian;Immormino,RobertM.;Gewirth,DanielT.;Chiosis,Gabriela[JournalofMedicinalChemistry,2006,vol.49,#1,p.381-390]

873436-91-0   
CASUnavailable 
  1289543-79-8 

[1]CurrentPatentAssignee:MEMORIALSLOAN-KETTERINGCANCERCENTER-WO2011/44394,2011,A1Locationinpatent:Page/Pagecolumn81

[2]Taldone,Tony;Zatorska,Danuta;Patel,HardikJ.;Sun,Weilin;Patel,MaulikR.;Chiosis,Gabriela[Heterocycles,2013,vol.87,#1,p.91-113]

8-(6-iodo-benzo1,3dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)adenine 
  145214-05-7    1289544-82-6 

[1]Patent:WO2011/44394,2011,A1.Locationinpatent:Page/Pagecolumn139

[2]Heterocycles,2013,vol.87,p.91-113

8-(6-iodo-benzo1,3dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)adenine 
  121359-48-6    1289544-83-7 

[1]Patent:WO2011/44394,2011,A1.Locationinpatent:Page/Pagecolumn139

[2]Heterocycles,2013,vol.87,p.91-113

[1]CurrentPatentAssignee:MEMORIALSLOAN-KETTERINGCANCERCENTER-WO2011/44394,2011,A1Locationinpatent:Page/Pagecolumn83

[2]Taldone,Tony;Zatorska,Danuta;Patel,HardikJ.;Sun,Weilin;Patel,MaulikR.;Chiosis,Gabriela[Heterocycles,2013,vol.87,#1,p.91-113]

Literature

Title: Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.

Journal: Journal of medicinal chemistry 20150514

Title: Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects.

Journal: Proceedings of the National Academy of Sciences of the United States of America 20120911

Title: Systematic identification of the HSP90 candidate regulated proteome.

Journal: Molecular & cellular proteomics : MCP 20120601

Title: Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.

Journal: PloS one 20100101

Title: The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1.

Journal: Journal of hematology & oncology 20100101

Title: Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.) 20090701

Title: Discovery and development of heat shock protein 90 inhibitors.

Journal: Bioorganic & medicinal chemistry 20090315

Title: Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling.

Journal: Bioorganic & medicinal chemistry 20080715

Title: The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20080326

Title: Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects.

Journal: Cancer research 20080101

Title: Synthesis of a red-shifted fluorescence polarization probe for Hsp90.

Journal: Bioorganic & medicinal chemistry letters 20060901

Title: Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors.

Journal: Journal of medicinal chemistry 20060810

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 873436-91-0
Tags:873436-91-0 Molecular Formula|873436-91-0 MDL|873436-91-0 SMILES|873436-91-0 Pu-h 71
Catalog No.: AA00GXXK
873436-91-0,MFCD18251588
873436-91-0 | Pu-h 71
Pack Size: 1mg
Purity: 98%
in stock
$30.00 $21.00
Pack Size: 5mg
Purity: 98%
in stock
$87.00 $61.00
Pack Size: 50mg
Purity: 98%
in stock
$373.00 $261.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00GXXK
Chemical Name: Pu-h 71
CAS Number: 873436-91-0
Molecular Formula: C18H21IN6O2S
Molecular Weight: 512.3678
MDL Number: MFCD18251588
SMILES: CC(NCCCn1c(Sc2cc3OCOc3cc2I)nc2c1ncnc2N)C
NSC Number: 752199
Properties
Complexity: 521  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 28  
Hydrogen Bond Acceptor Count: 8  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 7  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.2  
Downstream Synthesis Route
873437-14-0    873436-91-0 

[1]He,Huazhong;Zatorska,Danuta;Kim,Joungnam;Aguirre,Julia;Llauger,Laura;She,Yuhong;Wu,Nian;Immormino,RobertM.;Gewirth,DanielT.;Chiosis,Gabriela[JournalofMedicinalChemistry,2006,vol.49,#1,p.381-390]

873436-91-0   
CASUnavailable 
  1289543-79-8 

[1]CurrentPatentAssignee:MEMORIALSLOAN-KETTERINGCANCERCENTER-WO2011/44394,2011,A1Locationinpatent:Page/Pagecolumn81

[2]Taldone,Tony;Zatorska,Danuta;Patel,HardikJ.;Sun,Weilin;Patel,MaulikR.;Chiosis,Gabriela[Heterocycles,2013,vol.87,#1,p.91-113]

8-(6-iodo-benzo1,3dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)adenine 
  145214-05-7    1289544-82-6 

[1]Patent:WO2011/44394,2011,A1.Locationinpatent:Page/Pagecolumn139

[2]Heterocycles,2013,vol.87,p.91-113

8-(6-iodo-benzo1,3dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)adenine 
  121359-48-6    1289544-83-7 

[1]Patent:WO2011/44394,2011,A1.Locationinpatent:Page/Pagecolumn139

[2]Heterocycles,2013,vol.87,p.91-113

873436-91-0    55552-70-0    1289543-83-4 

[1]CurrentPatentAssignee:MEMORIALSLOAN-KETTERINGCANCERCENTER-WO2011/44394,2011,A1Locationinpatent:Page/Pagecolumn83

[2]Taldone,Tony;Zatorska,Danuta;Patel,HardikJ.;Sun,Weilin;Patel,MaulikR.;Chiosis,Gabriela[Heterocycles,2013,vol.87,#1,p.91-113]

Literature fold

Title: Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.

Journal: Journal of medicinal chemistry20150514

Title: Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects.

Journal: Proceedings of the National Academy of Sciences of the United States of America20120911

Title: Systematic identification of the HSP90 candidate regulated proteome.

Journal: Molecular & cellular proteomics : MCP20120601

Title: Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.

Journal: PloS one20100101

Title: The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1.

Journal: Journal of hematology & oncology20100101

Title: Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.)20090701

Title: Discovery and development of heat shock protein 90 inhibitors.

Journal: Bioorganic & medicinal chemistry20090315

Title: Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling.

Journal: Bioorganic & medicinal chemistry20080715

Title: The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience20080326

Title: Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects.

Journal: Cancer research20080101

Title: Synthesis of a red-shifted fluorescence polarization probe for Hsp90.

Journal: Bioorganic & medicinal chemistry letters20060901

Title: Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors.

Journal: Journal of medicinal chemistry20060810

Building Blocks More >
90032-83-0
90032-83-0
3,3,5,5-Tetramethylmorpholin-2-one
AA00GYAA | MFCD09722829
942047-63-4
942047-63-4
MELOXICAM-D3
AA00GZLP | MFCD08063461
889617-36-1
889617-36-1
3,3'-Methylenebis[1-(2,6-diisopropylphenyl)-3-imidazolium bromide]
AA00H05P | MFCD30475658
916971-29-4
916971-29-4
4-(2-Bromophenoxy)piperidine
AA00H0PJ | MFCD09861866
871673-24-4
871673-24-4
3-Amino-N-cyclopropylbenzamide
AA00H0XQ | MFCD07355824
905273-87-2
905273-87-2
6-Chloro-n,n-diisopropylnicotinamide
AA00H1AP | MFCD26127469
898544-48-4
898544-48-4
potassium [2-(azidomethyl)phenyl]trifluoroboranuide
AA00H1O3 | MFCD11052751
866132-59-4
866132-59-4
(2-Chlorobenzyl)(4-nitrophenyl)sulfane
AA00H1WL | MFCD03341001
917251-85-5
917251-85-5
8-Bromo-3-iodoquinoline
AA00H201 | MFCD09261261
89665-79-2
89665-79-2
(2-Chlorophenyl)methanesulfonamide
AA00H2NV | MFCD01240452
Submit
© 2017 AA BLOCKS, INC. All rights reserved.